Next Article in Journal
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study
Next Article in Special Issue
Recent Advances in Psychopharmacology
Previous Article in Journal
Navigating the Dry Eye Therapeutic Puzzle: A Mechanism-Based Overview of Current Treatments
Previous Article in Special Issue
Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes
 
 
Systematic Review

Article Versions Notes

Pharmaceuticals 2025, 18(7), 995; https://doi.org/10.3390/ph18070995
Action Date Notes Link
article xml file uploaded 2 July 2025 12:30 CEST Original file -
article xml uploaded. 2 July 2025 12:30 CEST Update https://www.mdpi.com/1424-8247/18/7/995/xml
article pdf uploaded. 2 July 2025 12:30 CEST Version of Record https://www.mdpi.com/1424-8247/18/7/995/pdf
article supplementary file uploaded. 2 July 2025 12:30 CEST - https://www.mdpi.com/1424-8247/18/7/995#supplementary
article html file updated 2 July 2025 12:35 CEST Original file https://www.mdpi.com/1424-8247/18/7/995/html
Back to TopTop